Kuleon

Curated by Signal

Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted treatments

Overview

Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted treatments. It offers a portfolio of serotonin receptor ligands that target neurocircuit abnormalities in the brain that are responsible to-treat disorders such as schizophrenia and depression.

Key facts

Founded: 2021
Headquarters: Seattle, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Althea Health
Virtual concierge service for providers and patients to manage various healthcare services
Health TechnologySan Jose, United States
PSI-Structural Genomics
Online search portal for discovering information on synthetic biology
Health TechnologyUnited States
PrimeTime Health Plan
Digital medical plan management platform for individuals
Health TechnologyCanton, United States

About Kuleon

What does Kuleon do?

Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted treatments.

Where is Kuleon headquartered?

Kuleon is headquartered in Seattle, United States.

When was Kuleon founded?

Kuleon was founded in 2021.

Which sector is Kuleon in?

Kuleon operates in Health Technology.

Who are Kuleon's competitors?

Companies similar to Kuleon include Althea Health, PSI-Structural Genomics, and PrimeTime Health Plan.